Pen-injector is a pre-filled disposable syringe-pen for multiple injections containing a hypoglycemic agent, an analogue of glucagon-like peptide-1 (GLP-1) — Semaglutide. Semaglutide pen (0.25 mg/dose, 0.5 mg/dose, 1.0 mg/dose) — a solution for subcutaneous administration in a pre-filled syringe-pen allows for the administration of doses of 0.25 mg, 0.5 mg and 1.0 mg. Syringe-pen is designed to titrate a dose of 0.25 mg and maintain a therapeutic dose of 0.5 mg and 1.0 mg.

Semaglutide is an analogue of glucagon-like peptide 1, which is produced in the human body and acts on receptors that control appetite and satiety, and also regulates insulin secretion.

Health benefits of semaglutide:
Semaglutide suppresses appetite and reduces calorie consumption by 18-35% during the day
Semaglutide reduces body weight primarily by reducing fat mass
Semaglutide reduces the risk of serious cardiovascular events
Semaglutide reduces triglyceride and cholesterol levels
Semaglutide reduces systolic blood pressure
Semaglutide reduces blood glucose levels in adults with type 2 diabetes (plasma glucose and glycated hemoglobin (HbA1c))